India Glycols · NSE: INDIAGLYCO · BSE: 500201

Q1 FY21 results · Apr–Jun 2020

India Glycols reported revenue from operations of ₹908.72 crore (down 35.7% from Q1 FY20) and net profit of ₹4.26 crore (down 87.5% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY21Q1 FY20YoYQ4 FY20QoQ
Revenue from operations908.721,412.96−35.7%1,526.90−40.5%
Other income1.453.25−55.4%1.86−22.0%
Total income910.171,416.21−35.7%1,528.76−40.5%
Profit before share of associates & JVs and tax6.6254.70−87.9%27.48−75.9%
Share of profit/(loss) of associates & JVs(0.35)(0.25)0.26
Net profit for the period4.2634.20−87.5%17.90−76.2%
EPS, basic (₹)1.3811.05−87.5%5.78−76.1%
Net margin (%)0.52.41.2

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ1 FY21Q1 FY20YoYQ4 FY20QoQ
Revenue from operations908.631,412.58−35.7%1,523.58−40.4%
Other income2.714.24−36.1%1.58+71.5%
Total income911.341,416.82−35.7%1,525.16−40.2%
Profit before tax11.3259.04−80.8%29.96−62.2%
Net profit for the period9.3138.79−76.0%20.11−53.7%
EPS, basic (₹)3.0112.53−76.0%6.50−53.7%
Net margin (%)1.02.71.3
Consolidated
Filed with BSE
14 Aug 2020, 16:38 IST
Board meeting
13 Aug 2020
Period
01 Apr 2020 to 30 Jun 2020
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
14 Aug 2020, 16:38 IST
Board meeting
13 Aug 2020
Period
01 Apr 2020 to 30 Jun 2020
Review status
Unaudited
Source
XBRL filing on BSE